ATE461694T1 - Pharmazeutische indapamid-zusammensetzung mit verzögerter freisetzung - Google Patents

Pharmazeutische indapamid-zusammensetzung mit verzögerter freisetzung

Info

Publication number
ATE461694T1
ATE461694T1 AT05707079T AT05707079T ATE461694T1 AT E461694 T1 ATE461694 T1 AT E461694T1 AT 05707079 T AT05707079 T AT 05707079T AT 05707079 T AT05707079 T AT 05707079T AT E461694 T1 ATE461694 T1 AT E461694T1
Authority
AT
Austria
Prior art keywords
sustained release
indapamid
composition
release pharmaceutical
indapamide
Prior art date
Application number
AT05707079T
Other languages
English (en)
Inventor
Andrejka Kramar
Franc Vrecer
Irena Petrisic
Stanka Perc
Original Assignee
Krka Tovarna Zdravil D D Novo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil D D Novo filed Critical Krka Tovarna Zdravil D D Novo
Application granted granted Critical
Publication of ATE461694T1 publication Critical patent/ATE461694T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05707079T 2004-01-30 2005-01-28 Pharmazeutische indapamid-zusammensetzung mit verzögerter freisetzung ATE461694T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004005009A DE102004005009A1 (de) 2004-01-30 2004-01-30 Verzögert freisetzende pharmazeutische Zusammensetzung von Indapamid
PCT/EP2005/000886 WO2005074884A2 (en) 2004-01-30 2005-01-28 Sustained release pharmaceutical composition of indapamide

Publications (1)

Publication Number Publication Date
ATE461694T1 true ATE461694T1 (de) 2010-04-15

Family

ID=34813079

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05707079T ATE461694T1 (de) 2004-01-30 2005-01-28 Pharmazeutische indapamid-zusammensetzung mit verzögerter freisetzung

Country Status (8)

Country Link
EP (1) EP1713452B1 (de)
AT (1) ATE461694T1 (de)
DE (2) DE102004005009A1 (de)
EA (1) EA011810B1 (de)
NO (1) NO20063868L (de)
UA (1) UA89628C2 (de)
WO (1) WO2005074884A2 (de)
ZA (1) ZA200607156B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004062257A1 (de) * 2004-12-23 2006-07-06 Merckle Gmbh Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung
RU2288713C1 (ru) * 2005-10-27 2006-12-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Состав пролонгированного действия, обладающий антигипертензивной и диуретической активностью, и способ его получения
PL204780B1 (pl) * 2006-06-02 2010-02-26 Zak & Lstrok Ady Farmaceutyczn Tabletka powlekana o przedłużonym uwalnianiu substancji aktywnej otrzymywana metodą bezpośredniego tabletkowania zawierająca indapamid albo jego farmaceutyczną sól oraz farmaceutycznie dopuszczalne wypełniacze, zastosowanie karbomeru do wytwarzania tabletki oraz sposób jej powlekania
EP2380561A1 (de) 2010-04-21 2011-10-26 LEK Pharmaceuticals d.d. Zusammensetzung mit verlängerter Freisetzung enthaltend Indapamid
CN105012275B (zh) * 2015-08-20 2018-03-27 广东安诺药业股份有限公司 吲达帕胺缓释剂制备方法
EP4103158B1 (de) * 2020-02-10 2024-09-04 Adamed Pharma S.A. Zusammensetzung mit ramipril und indapamid
CZ309820B6 (cs) * 2021-04-23 2023-11-08 Pro.Med.Cs Praha A.S. Způsob přípravy pevné lékové formy obsahující kompozici s nízkým obsahem účinné látky

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
EP1057479A1 (de) * 1994-12-14 2000-12-06 Enbalt Trading Limited Pharmazeutische Zubereitung zur Direktverpressung
PL193976B1 (pl) * 2002-07-01 2007-04-30 Pliva Krakow Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid

Also Published As

Publication number Publication date
EP1713452A2 (de) 2006-10-25
WO2005074884A3 (en) 2005-12-08
DE602005020116D1 (de) 2010-05-06
UA89628C2 (ru) 2010-02-25
ZA200607156B (en) 2007-11-28
EA200600957A1 (ru) 2006-12-29
DE102004005009A1 (de) 2005-09-01
WO2005074884A2 (en) 2005-08-18
EP1713452B1 (de) 2010-03-24
EA011810B1 (ru) 2009-06-30
NO20063868L (no) 2006-10-20

Similar Documents

Publication Publication Date Title
SG153800A1 (en) Pharmaceutical compositions
EA200701065A1 (ru) Инъецируемые составы, содержащие нанодисперсный оланзапин
CY1117524T1 (el) Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες
ATE502921T1 (de) Substituierte indole
UA94942C2 (ru) Фармацевтические композиции с ингибиторами dpp iv
TNSN07020A1 (en) Her2 antibody composition
ATE509634T1 (de) Pharmazeutische formulierungen mit incretin- peptid und aprotisch-polarem lösungsmittel
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
EA200901319A1 (ru) Композиции для назального введения
MX2010007150A (es) Formulaciones del factor de von-willebrand recombinante.
CR9081A (es) Inhibidores de la interaccion entre mdm2 y p53
MX2010004028A (es) 4-[3-(4-ciclopropancarbonil-piperacin-1-carbonil)-4-fluoro-bencil ]-2h-ftalacin-1-ona.
EA201001711A1 (ru) Смесь связанного триптофана в составе пептидов и связанного триптофана в составе полипептидов
EA200700312A1 (ru) Композиции для доставки лекарственных средств с высокой водорастворимостью
ATE555156T1 (de) Sauerstofffänger-mischungen
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
EA201170512A1 (ru) Композиция для перорального введения
HN2003000406A (es) Clinker y cemento blanco con alto contenido de azufre, usado como combustible
EA200700367A1 (ru) Новые производные 4-бензилиденпиперидина
ATE461694T1 (de) Pharmazeutische indapamid-zusammensetzung mit verzögerter freisetzung
TW200738649A (en) Calcilytic compounds
PL1765310T3 (pl) Mieszanina do podawania przezskórnego nisko- i wysokocząsteczkowych związków
TR201109686T2 (tr) Olmesartan'ın Farmasötik Bileşimleri.
DE602005023986D1 (de) Mischkristalle sowie sie enthaltende pharmazeutische zusammensetzungen
EA201170180A1 (ru) Фармацевтические композиции соматотропных гормонов

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties